Connect with us
European Gaming Congress 2024

Artificial Intelligence

Healthcare Advertising Market is Likely to Upsurge USD 35.01 Billion Globally by 2029, Size, Share, Trends, Demand, Growth and Opportunity Analysis

Published

on

<!– Name:DistributionId Value:8751604 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5377 –> <!– Name:CustomerId Value:1201301 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:f2ef783f-af38-44c3-a9b4-3858d30c4507 –>

NEW YORK, Feb. 20, 2023 (GLOBE NEWSWIRE) — “Healthcare Advertising Market” is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter’s Five Forces analysis, and competitive environment are all dissected in detail in the research. The Healthcare Advertising market research report is a resource, which offers current as well as upcoming technical and financial details of the Healthcare Advertising industry for the specific forecast period. The report exhibits important product developments and tracks recent acquisitions, mergers, and research in the Healthcare Advertising industry by the key players. The market report is a precise study of the Healthcare Advertising industry which explains the market definition, classifications, applications, engagements, and global industry trends. The leading Healthcare Advertising market report is sure to help businesses for long-lasting accomplishments in terms of better decision-making, revenue generation, prioritizing market goals, and profitable business.

Data Bridge Market Research analyses that the healthcare advertising market was valued at USD 32.76 billion in 2021 is expected to reach the value of USD 35.01 billion by 2029, at a CAGR of 5.2% during the forecast period. The major factors driving the growth of the healthcare advertising market are an increase in the rate of digitization, particularly in developing economies, growing adoption of risk management software solutions by small and medium-sized businesses, and an increase in the proliferation rate of smartphones.

Get a Sample PDF of the Healthcare Advertising Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-healthcare-advertising-market

Healthcare advertising is defined as the promotion of healthcare and pharmaceutical products to the general public with the goal of raising awareness about various ailments and the various treatments and procedures available on the market.

Advertisement
Stake.com

Healthcare advertising is becoming increasingly important in raising awareness about various diseases and health issues, as well as the drugs and procedures needed for treatment. Unlike advertising in other industries, healthcare advertising is unique and subject to a plethora of regulations. Advertising in the healthcare industry is governed not only by the Federal Trade Commission and state consumer protection agencies, but also by a number of other regulatory bodies.

Important Features that are under Offering Market Highlights of the Reports:

  • Detailed overview of this market
  • Changes in industry market dynamics
  • Detailed market segmentation by type, application, etc.
  • Historical, current, and projected market size in terms of quantity and value
  • Recent industry trends and developments
  • Competition situation of this Market
  • Key companies and product strategies
  • Potential niche segment/region showing promising growth.

Finally, this Market Report is the authoritative source for market research that can dramatically accelerate your business. The report shows economic conditions such as major locales, item values, profits, limits, generation, supply, requirements, market development rates, and numbers

Top Leading Key Players of the Healthcare Advertising Market:

  • Xandr Inc. (U.S)
  • Verizon (U.S)
  • Kayzen (China)
  • NextRoll, Inc. (U.S)
  • Google (U.S)
  • Adobe (U.S)
  • Magnite, Inc (U.S)
  • MediaMath (U.S)
  • IPONWEB Limited (U.S)
  • VOYAGE GROUP (Japan)
  • Integral Ad Science Inc.(Denmark)
  • The Trade Desk (U.S)
  • Connexity (U.S)
  • Centro, Incorporated (U.S)
  • RhythmOne, LLC (U.S)

Why to consider this report?

  • The report offers a comprehensive evaluation of the Global Healthcare Advertising Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Access Full PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-healthcare-advertising-market

Healthcare Advertising Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Advertisement
Stake.com
  • Increase in the investments for healthcare advertising

Increasing investments in healthcare advertising are assisting in the expansion of this market. Healthcare advertising is a service that creates, plans, and manages advertising and other forms of promotion for its clients. Advertising services such as mobile first websites, online advertising, search engine optimization, social media advertising, newspapers, magazines, and medical journals, television ads, radio ads, and others are provided by separate marketing agencies.

  • Use of healthcare advertising in various application

Healthcare advertising is used in a variety of applications in the healthcare sector, including medical insurance, over-the-counter medicines, hygiene products, pharmaceutical manufacturers and brands, prescription medicines, fitness and diet products and services, medical equipment, and corrective lenses and glasses.

Restraints

Lack of technological expertise in developing and underdeveloped economies, as well as the complexity associated with software installation and configuration, will act as growth restraints for the market. Furthermore, the decline in awareness and in backward economies, as well as the high costs of deploying, will slow the market’s growth rate yet again. The lack of strong infrastructure in backward economies will also pose a challenge to market growth rates.

The investment made in the study would provide you access to information such as:

  • Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
  • Country-wise Market Size Split [of important countries with major market share]
  • Market Share and Revenue/Sales by leading players
  • Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
  • Market Size
  • Market Size by application/industry verticals
  • Market Projections/Forecast

Healthcare Advertising Market Segmentations:

Type

  • Traditional
  • Public relation
  • Unique branding and awareness
  • Internal marketing
  • Employer marketing
  • Physician referrals

Form of engagement

  • Healthcare facility
  • In home / in person

Technology

  • Artificial intelligence
  • Personal data tracking

Approach

  • Detailing (healthcare professional)
  • Direct to consumer advertising

Format

Application

Advertisement
Stake.com
  • Fitness & diet product & service
  • Over the counter
  • Health hygiene
  • Medical insurance
  • Corrective lenses & glasses
  • Medical devices & equipment
  • Pharmaceutical
  • Prescription medicines
  • Biotech companies

To Gain More Insights into the Market Analysis, Visit https://www.databridgemarketresearch.com/reports/global-healthcare-advertising-market

Healthcare Advertising Market Country-Level Analysis

The countries covered in the Healthcare Advertising Market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

The country section of the Healthcare Advertising market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Table of Content

  1. Introduction
  2. Executive Summary
  3. Premium Insights
  4. Market Overview
  5. Global Healthcare Advertising Market, By Type
  6. Global Healthcare Advertising Market, By Form of engagement
  7. Global Healthcare Advertising Market, By Technology
  8. Global Healthcare Advertising Market, By Approach
  9. Global Healthcare Advertising Market, By Format
  10. Global Healthcare Advertising Market, By Application
  11. Global Healthcare Advertising Market, By Region
  12. Global Healthcare Advertising Market, Company Landscape
  13. SWOT Analysis
  14. Company Profile
  15. Questionnaire
  16. Related Reports

Table of Content, Request TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-healthcare-advertising-market

Browse Related Reports:

Advertisement
Stake.com
  • Asia-Pacific Healthcare Advertising Market, By Type (Traditional, Online, Public Relations, Unique Branding and Awareness, Internal Marketing, Employer Marketing, Physician Referrals, Others), Form of Engagement (Healthcare Facility, Digital, In Home/Person, Others), Technology (Telemedicine, Artificial Intelligence, Personal Data Tracking, Others), Approach (Detailing (Health Professionals), Direct-to-Customer Advertising), Format (Display, Search, Video), Applications (Pharmaceutical Advertising, Biopharmaceuticals, Vaccines, Over-The-Counter Drugs, Prescription Medicines, Medical Device and Equipment, Biotech Companies, Medical Insurance, Fitness and Diet Products, Hygiene Products, Others) – Industry Trends and Forecast to 2029: https://www.databridgemarketresearch.com/reports/asia-pacific-healthcare-advertising-market
  • Middle East and Africa Healthcare Advertising Market, By Type (Traditional, Online, Public Relations, Unique Branding and Awareness, Internal Marketing, Employer Marketing, Physician Referrals and Others), Form of Engagement (Healthcare Facility, Digital, In Home/In Person and Others), Technology (Telemedicine, Artificial Intelligence, Personal Data Tracking and Others), Approach (Detailing (Health Professionals) and Direct-to-Consumer Advertising), Format (Display, Search and Video), Application (Pharmaceuticals (Small Molecule Drugs) Advertising, Biopharmaceuticals, Vaccines, Over-the-Counter Drugs, Prescription Medicines, Medical Devices and Equipment, Biotech Companies, Medical Insurance, Fitness & Diet Products & Service, Hygiene Products, Corrective Lenses & Glasses and Others) – Industry Trends and Forecast to 2029: https://www.databridgemarketresearch.com/reports/middle-east-and-africa-healthcare-advertising-market
  • North America Healthcare Advertising Market, By Type (Traditional, Online, Public Relations, Unique Branding and Awareness, Internal Marketing, Employer Marketing, Physician Referrals and Others), Form of Engagement (Healthcare Facility, Digital, In Home/In Person and Others), Technology (Telemedicine, Artificial Intelligence, Personal Data Tracking and Others), Approach (Detailing (Health Professionals) and Direct-to-Consumer Advertising), Format (Display, Search and Video), Application (Pharmaceuticals (Small Molecule Drugs) Advertising, Biopharmaceuticals, Vaccines, Over-the-Counter Drugs, Prescription Medicines, Medical Devices and Equipment, Biotech Companies, Medical Insurance, Fitness & Diet Products & Service, Hygiene Products, Corrective Lenses & Glasses and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027: https://www.databridgemarketresearch.com/reports/north-america-healthcare-advertising-market
  • Europe Healthcare Advertising Market, By Type (Online, Traditional, Physician Referrals, Internal Marketing, Public Relations, Employer Marketing, Unique Branding and Awareness and Others), Form of Engagement (Healthcare Facility, In Home / In Person, Digital and Others), Technology (Telemedicine, Artificial Intelligence, Personal Data Tracking and Others), Approach (Detailing (Healthcare Professional) and Direct to Consumer Advertising), Format (Display, Search and Video), Application (Pharmaceuticals (Small Molecule Drugs) Advertising, Biopharmaceuticals, Vaccines, Over-The-Counter Drugs, Prescription Medicines, Medical Devices and Equipment, Biotech Companies, Medical Insurance, Fitness & Diet Products & Service, Hygiene Products, Corrective Lenses & Glasses and Others) – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/europe-healthcare-advertising-market
  • Contextual Advertising Market, By Deployment (Mobile Devices, Desktops, Digital Billboards), Approach (Mass Contextual Advertising, Focused Contextual Advertising, Contextual Behavioral Advertising, Contextual Billboard Advertising), Type (Activity-Based Advertising, Location-Based Advertising, Others), End User (Consumer Goods, Retail and Restaurants, Telecom and IT, Banking, Financial Services, and Insurance, Media and Entertainment, Travel, Transportation, Automobiles, Healthcare, Academia, Government), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-contextual-advertising-market
  • Mobile Advertising Market, By Format (Search, Native Social, Display, In-App, Websites, Video, and Short Message Service (SMS)), Category (Art and Entertainment, Hobbies and Interests, and Others), Solution (Mobile Advertising Network, Mobile Advertising Platform, Mobile Advertising Server and Others), Industry Vertical (Media and Entertainment, Banking, Financial Services and Insurance (BFSI), Education, Government, Fast Moving Consumable Goods (FMCG), Healthcare and Others), Mobile Devices (Smartphones, Tablets, Laptops and Notebooks and Other Devices), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-mobile-advertising-market
  • Asia-Pacific Healthcare Advertising Market, By Type (Traditional, Online, Public Relations, Unique Branding and Awareness, Internal Marketing, Employer Marketing, Physician Referrals, Others), Form of Engagement (Healthcare Facility, Digital, In Home/Person, Others), Technology (Telemedicine, Artificial Intelligence, Personal Data Tracking, Others), Approach (Detailing (Health Professionals), Direct-to-Customer Advertising), Format (Display, Search, Video), Applications (Pharmaceutical Advertising, Biopharmaceuticals, Vaccines, Over-The-Counter Drugs, Prescription Medicines, Medical Device and Equipment, Biotech Companies, Medical Insurance, Fitness and Diet Products, Hygiene Products, Others) https://www.databridgemarketresearch.com/reports/asia-pacific-healthcare-advertising-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- [email protected]

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa

Published

on

juniper-biologics-expands-distribution-rights-for-caris-life-sciences’-molecular-profiling-in-the-middle-east-and-africa

SINGAPORE, June 23, 2024 /PRNewswire/ — Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)’ solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion follows the initial January 2023 distribution rights partnership with Caris for the same services in Southeast Asia (SEA). Juniper is now poised to offer Caris’ advanced solid tumour molecular profiling services across a broader region, enhancing patient access to personalised treatment options.

Caris’ best-in-class molecular profiling, combined with proprietary artificial intelligence, provides more precise and individualized cancer treatments. This profiling approach assesses DNA, RNA, and proteins, revealing a molecular blueprint that identifies treatment options specific to each patient’s cancer. Caris has developed the world’s largest and most informative platform for cancer analysis, featuring the most advanced tumour profiling available, including Whole Exome and Whole Transcriptome Sequencing across over 23,000 genes. By analysing biomarkers found in tumours, Caris helps healthcare providers make informed choices for personalised care.
Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper’s collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced therapies is limited.
Raman Singh, Founder and Chief Executive Officer (CEO) of Juniper Biologics, spoke on the successful acquisition: “Caris molecular profiling bridges the gap between tumour biology and cancer treatments, guiding precision medicine through personalised treatment selection for physicians and their patients. Our exclusive partnership with Caris Life Sciences to distribute this service in the Middle East and Africa will significantly empower healthcare professionals to make informed decisions for their patients. This service enables oncologists to recommend highly personalised treatments that specifically target a patient’s cancer, thereby improving and expanding their care options. This targeted approach offers patients, particularly those with rare or aggressive cancers, an improved quality of life.”
“Caris is pleased to expand the distribution of our molecular profiling services in the Middle East and Africa through our partnership with Juniper Biologics,” said Caris President David Spetzler, MS, PhD, MBA. “This collaboration aligns with Caris’ goal of enabling clinicians worldwide to make the best individualised treatment choices for their patients and ultimately helping to improve patient outcomes.”
This partnership marks a significant milestone in expanding access to personalised medicine and advanced cancer treatment technologies in the Middle East and Africa.
About Juniper Biologics
Backed by The Sylvan Group, Juniper Biologics is a science-led healthcare company focused on delivering novel therapies to improve the health and quality of life of patients, by building a growing presence in Oncology and Oncology Supportive Care, Rare/Orphan Diseases and Gene Therapy. It was founded on a vision to provide treatments for unmet medical needs focused on specialist therapy areas in which it can make the most difference. Through bold and transformative science, Juniper Biologics is committed to creating possibilities that have the potential to become the next generation of life-changing medicines for patient communities in China, Japan, Asia, Australia, New Zealand, Middle East, and Africa.
Website: https://www.juniperbiologics.com/
LinkedIn: https://www.linkedin.com/company/juniper-biologics
About Caris Life SciencesCaris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyse and unravel the molecular complexity of disease. This convergence of sequencing power, big data, and AI technologies provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection, and drug development.
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia, and other international markets. To learn more, please visit CarisLifeSciences.com.
 

View original content:https://www.prnewswire.co.uk/news-releases/juniper-biologics-expands-distribution-rights-for-caris-life-sciences-molecular-profiling-in-the-middle-east-and-africa-302179643.html

Continue Reading

Artificial Intelligence

2024 Tang Prize Laureates Announced: Six Global Visionaries to Be Honored in Taiwan This September

Published

on

2024-tang-prize-laureates-announced:-six-global-visionaries-to-be-honored-in-taiwan-this-september

TAIPEI, June 22, 2024 /PRNewswire/ — The prestigious 2024 Tang Prize Laureates have been announced, recognizing outstanding contributions in various fields. The Tang Prize in Sustainable Development is awarded to American chemist Omar M. Yaghi. In the field of Biopharmaceutical Science, the prize is jointly awarded to Joel F. Habener, Svetlana Mojsov, and Jens Juul Holst. University Professor Emeritus Hsu Cho-yun of the University of Pittsburgh and Academician of Academia Sinica is honored with the Tang Prize in Sinology. Mary Robinson, a former lawyer and senator, former president of Ireland, former United Nations High Commissioner for Human Rights, and current Chair of The Elders, is awarded the Tang Prize in Rule of Law. These six distinguished laureates will be formally honored at an upcoming ceremony to be held in Taiwan this September.

The Tang Prize in Sustainable Development is awarded to Omar M. Yaghi, for his extraordinary contributions to sustainable development, particularly his pioneering work with Metal-Organic Frameworks (MOFs) and other ultra-porous frameworks that can be tailored for carbon capture, hydrogen and methane storage, and water harvesting from desert air. His research has revolutionized the field of chemistry and materials science, offering transformative solutions for sustainable development through the creation of customizable materials with exceptional properties.
Professor Joel F. Habener, Professor Svetlana Mojsov, and Professor Jens Juul Holst have been jointly awarded the Tang Prize in Biopharmaceutical Science, for the discovery of GLP-1 (7-37) as an insulinotropic factor and the development of GLP-1 (7-37)-based anti-diabetic and anti-obesity drugs.
University Professor Emeritus Hsu Cho-yun is awarded the Tang Prize in Sinology for his exceptional contributions to the field of Sinology. Professor Hsu’s illustrious academic career has been distinguished by his holistic approach to the study of ancient Chinese history, seamlessly integrating an exploration of cultural and intellectual exchanges between China and the world. With his profound erudition and unwavering public spirit, Professor Hsu embodies the quintessential Sinologist, possessing both a deep historical sensibility and a broad, worldly vision.
The Tang Prize in Rule of Law is awarded to Professor Mary Robinson, for her “powerful advocacy for the most disadvantaged in different spheres, including gender equality, poverty alleviation, human rights, and climate justice.” In particular, the Selection Committee noted that her “passionate endeavors demonstrated an effective combination of legal acumen and practical solutions.” The Committee also noted that “from the national to the global stage, legal and political, she has innovatively transformed and expanded the various positions in which she has served to strengthen the rule of law.”
About the Tang Prize
Since the advent of globalization, mankind has been able to enjoy the convenience brought forth by the advancement of human civilization and science. Yet a multitude of challenges, such as climate change, the emergence of new infectious diseases, wealth gap, and moral degradation, have surfaced along the way. Against this backdrop, Dr. Samuel Yin established the Tang Prize in December 2012. It consists of four award categories, namely Sustainable Development, Biopharmaceutical Science, Sinology, and Rule of Law. Every other year, four independent and professional selection committees, comprising many internationally renowned experts, scholars, and Nobel winners, choose as Tang Prize laureates people who have influenced and made substantive contributions to the world, regardless of ethnicity, nationality or gender. A cash prize of NT$50 million (approx. US$1.7 million) is allocated to each category, with NT$10 million (approx. US$ 0.35 million) of it being a research grant intended to encourage professionals in every field to examine mankind’s most urgent needs in the 21st century, and become leading forces in the development of human society through their outstanding research outcomes and active civic engagement.
Photo – https://mma.prnewswire.com/media/2444565/2024.jpg

View original content:https://www.prnewswire.co.uk/news-releases/2024-tang-prize-laureates-announced-six-global-visionaries-to-be-honored-in-taiwan-this-september-302179271.html

Continue Reading

Artificial Intelligence

Key Tech Stocks Optimizing AI Usability and Infrastructure for a $20-Trillion Future

Published

on

key-tech-stocks-optimizing-ai-usability-and-infrastructure-for-a-$20-trillion-future

USA News Group CommentaryIssued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 21, 2024 /PRNewswire/ — USA News Group – Several big winners have been made already in the ongoing artificial intelligence (AI) revolution. However, there’s clearly none bigger than chipmaking giant NVIDIA Corporation (NASDAQ: NVDA), which just surpassed two of its big tech peers to become the most valued publicly-traded company on the planet. To put it into perspective, NVIDIA’s market cap is currently larger than each of Europe’s largest stock markets, while lucky investors who bet $1000 on NVIDIA stock just ten years ago would be sitting on an extra $297,600 today. Now as analysts are predicting that AI and cryptocurrency could inject $20 trillion into the global economy by 2030, the best minds in the tech sector are moving their pieces into place to secure their piece of the pie. Behind the scenes, tech stocks are optimizing the infrastructure, security, and usability of AI, including new developments from Avant Technologies Inc. (OTCQB: AVAI), International Business Machines Corporation (IBC) (NYSE: IBM), Cloudflare, Inc. (NYSE: NET), and Accenture plc (NYSE: ACN).

Known as a pioneer in the sector for its innovative AI technology, Avant Technologies Inc. (OTCQB: AVAI) has improved its main product, Avant AI™. This sophisticated AI system, celebrated for its advanced machine and deep learning capabilities, is adaptable across a wide range of industries.
In a recent strategic development, Avant has signed a Binding Letter of Intent (BLOI) with Flow Wave, LLC (FW), a Florida-based leader in immersible computer server technology. This agreement allows Avant to acquire up to 50 cutting-edge immersible computer servers from FW in a deal valued at $50 million.
“Avant’s revolutionary AI software platform is poised to transform the landscape of data center management,” said William Hisey, CEO of Avant.  “By integrating proprietary machine learning algorithms with open-source innovations into these servers, Avant is developing a highly intelligent system designed to optimize resource allocation, enhance performance, and drive unprecedented levels of efficiency and automation. This marks the beginning of a new era for Avant Technologies, positioning us at the forefront of the supercomputer-driven data center industry and setting new standards for managing and storing AI applications.”
Flow Wave Immersible AI Supercomputer Servers are great for heavy AI and machine learning tasks because they have strong processing power, meaning they can analyze data faster and more efficiently. Their special cooling technology uses less energy, saving money and reducing environmental impact. The servers are also compact and easy to set up, making them ideal for data centers with limited space. Plus, their design helps them last longer and require less maintenance.
Avant plans to tackle the challenges of the digital age by buying up to 50 of these high-performance servers from Flow Wave. These servers, with their advanced cooling technology, boost performance and save energy. This deal shows Avant’s dedication to providing top-notch AI infrastructure and improving efficiency. More details about the transaction will be shared once a definitive agreement is finalized.
One of the most active tech giants in the AI space is International Business Machines Corporation (IBC) (NYSE: IBM), which recently released a new methodology through its IBM Research® wing called LAB (Large-Scale Alignment for ChatBots), through an open-source project called InstructLab with its subsidiary Red Hat®, which IBM acquired for $34 billion in 2019. The InstructLab project builds on the LAB technique for a community-driven approach to language model development through skills and knowledge training.
As well, IBM has teamed up with WPP and LinkedIn to launch a new business-to-business (B2B) solution powered by IBM’s AI and data platform watsonx, designed to reinvent how B2B markets identify and engage clients and prospects across the buying journey. WPP Open for B2B will help marketers solve complex B2B marketing challenges, accurately identify and engage buying groups, and improve clients’ return on investment.
“B2B marketers have been focused on creating truly personalized, relevant and consistent experiences for buying groups at scale for years,” said Jonathan Adashek, Senior Vice President of Marketing and Communications at IBM. “Our collaboration with WPP and LinkedIn provides real-time, actionable insights that are based on trusted data. We are excited to create and use these new, powerful and trusted AI solutions to deliver a force multiplier for B2B marketing.”
Cloud-based security solution provider Cloudflare, Inc. (NYSE: NET) recently announced the general availability of its AI Gateway platform, dubbed as a unified interface for managing and scaling the generative AI workloads of clients. Since its beta launch in September 2023, AI Gateway has handled over 500 million requests and is now ready for full client use.
The general availability release followed upon another Cloudflare announcement of a collaboration with Hugging Face, the leading open and collaborative platform for AI builders, for a one-click-simple global deployment for AI applications. With its Workers AI platform now generally available, Cloudflare became the first serverless inference partner integrated on the Hugging Face Hub for deploying models, enabling developers to quickly, easily, and affordably deploy AI globally, without managing infrastructure or paying for unused compute capacity.
“Workers AI is one of the most affordable and accessible solutions to run inference,” said Matthew Prince, CEO and co-founder, Cloudflare. “With Hugging Face and Cloudflare both deeply aligned in our efforts to democratize AI in a simple, affordable way, we’re giving developers the freedom and agility to choose a model and scale their AI apps from zero to global in an instant.”
Reporting impressive generative AI revenues in its latest Q3 2024 fiscal results has caused shares of Accenture plc (NYSE: ACN) to jump this week, reporting more than $900 million in generative AI bookings in the latest quarter alone.
“Our actions to stay laser-focused on the needs of our clients are clear in our third quarter results,” said Julie Sweet, Chair and CEO of Accenture. “We… achieved two significant milestones this quarter — with $2 billion in Generative AI sales year-to-date and $500 million in revenue year-to-date — which demonstrate our early lead in this critical technology.”
Prior to the financial report, Accenture announced its intent to acquire Italian-based network services company, Fibermind, which specializes in fiber and mobile 5G networks deployment, as well as infrastructure engineering services. Together, Accenture and Fibermind will offer clients network engineering capabilities, deep industry knowledge, and technology assets powered by automation, robotics, data and AI.
Prior to its surge into the position as the world’s most valuable publicly-traded company, NVIDIA Corporation (NASDAQ: NVDA) made a pair of announcements, further cementing its role in the AI revolution.
The first was the announcement of its NVIDIA Omniverse Cloud Sensor RTX, a set of microservices that enable physically accurate sensor simulation to accelerate the development of fully autonomous machines of every kind, allowing developers to test sensor perception and associated AI software at scale in physically accurate, realistic virtual environments prior to real-world deployment.
The second announcement was the NVIDIA AI Computing by HPE, a portfolio of AI solutions and joint go-to-market integrations that enable enterprises to accelerate adoption of generative AI, co-developed with Hewlett Packard (HP).
“Generative AI and accelerated computing are fueling a fundamental transformation as every industry races to join the industrial revolution,” said Jensen Huang, Founder and CEO of NVIDIA. “Never before have NVIDIA and HPE integrated our technologies so deeply – combining the entire NVIDIA AI computing stack along with HPE’s private cloud technology – to equip enterprise clients and AI professionals with the most advanced computing infrastructure and services to expand the frontier of AI.”
All NVIDIA AI Computing offerings by HPE will be available through a combined marketing strategy involving sales teams, channel partners, and training. This strategy includes a global network of system integrators such as Deloitte, HCLTech, Infosys, TCS, and Wipro. These integrators will assist enterprises across various industries in running complex AI workloads.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 
CONTACT:
USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/key-tech-stocks-optimizing-ai-usability-and-infrastructure-for-a-20-trillion-future-302179234.html

Continue Reading

Trending